Dual‐functional lipid polymeric hybrid pH‐responsive nanoparticles decorated with cell penetrating peptide and folate for therapy against rheumatoid arthritis

[1]  H. Hatakeyama.  Recent Advances in Endogenous and Exogenous Stimuli-Responsive Nanocarriers for Drug Delivery and Therapeutics. , 2017, Chemical & pharmaceutical bulletin.

[2]  R. Reis,et al.  Mastocarcinoma therapy synergistically promoted by lysosome dependent apoptosis specifically evoked by 5‐Fu@nanogel system with passive targeting and pH activatable dual function , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[3]  Saji Uthaman,et al.  Bioreducible branched poly(modified nona‐arginine) cell‐penetrating peptide as a novel gene delivery platform , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[4]  Xun Sun,et al.  Targeted delivery of low-dose dexamethasone using PCL-PEG micelles for effective treatment of rheumatoid arthritis. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[5]  A. Gomes,et al.  Folate-targeted nanoparticles for rheumatoid arthritis therapy. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[6]  Xuesi Chen,et al.  Activated macrophage-targeted dextran-methotrexate/folate conjugate prevents deterioration of collagen-induced arthritis in mice. , 2016, Journal of materials chemistry. B.

[7]  K. Lee,et al.  The spacer arm length in cell-penetrating peptides influences chitosan/siRNA nanoparticle delivery for pulmonary inflammation treatment. , 2015, Nanoscale.

[8]  Xinmei Wang,et al.  Fatty acid modified octa-arginine for delivery of siRNA. , 2015, International journal of pharmaceutics.

[9]  D. Jo,et al.  Hyaluronan nanoparticles bearing γ-secretase inhibitor: in vivo therapeutic effects on rheumatoid arthritis. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[10]  Helena Canhão,et al.  FRI0298 The Impact of DMARD Co-Therapy on Abatacept Effectiveness in Rheumatoid Arthritis Patients. A Pan-European Analysis of RA Registries , 2014 .

[11]  Désirée van der Heijde,et al.  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update , 2013, Annals of the rheumatic diseases.

[12]  N. Murthy,et al.  Delivery of Nox2-NADPH oxidase siRNA with polyketal nanoparticles for improving cardiac function following myocardial infarction. , 2013, Biomaterials.

[13]  Tianyue Jiang,et al.  Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery. , 2012, Biomaterials.

[14]  B. Mishra,et al.  Methotrexate: a detailed review on drug delivery and clinical aspects , 2012, Expert opinion on drug delivery.

[15]  Georg Schett,et al.  The pathogenesis of rheumatoid arthritis. , 2011, The New England journal of medicine.

[16]  O. Farokhzad,et al.  Differentially charged hollow core/shell lipid-polymer-lipid hybrid nanoparticles for small interfering RNA delivery. , 2011, Angewandte Chemie.

[17]  J. O'dell,et al.  State-of-the-art: rheumatoid arthritis , 2010, Annals of the rheumatic diseases.

[18]  John Wong,et al.  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs , 2010, Annals of the rheumatic diseases.

[19]  J. Xue,et al.  Gene transfer using self-assembled ternary complexes of cationic magnetic nanoparticles, plasmid DNA and cell-penetrating Tat peptide. , 2010, Biomaterials.

[20]  Robert Langer,et al.  Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform. , 2008, ACS nano.

[21]  Robert H Pierce,et al.  Polyketal copolymers: a new acid-sensitive delivery vehicle for treating acute inflammatory diseases. , 2008, Bioconjugate chemistry.

[22]  G. Burmester,et al.  Cells of the synovium in rheumatoid arthritis. Macrophages , 2007, Arthritis research & therapy.

[23]  J. O'dell,et al.  Therapeutic strategies for rheumatoid arthritis. , 2004, The New England journal of medicine.

[24]  Philip S Low,et al.  Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis. , 2004, Advanced drug delivery reviews.

[25]  G. Firestein.  Evolving concepts of rheumatoid arthritis , 2003, Nature.